Name:  ___              Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: SURGERY
 
Allergies: 
No Known Allergies / Adverse Drug Reactions
 
Attending: ___.
 
Chief Complaint:
Morbid obesity
 
Major Surgical or Invasive Procedure:
___: laparoscopic sleeve gastrectomy
 
History of Present Illness:
___ is a ___ female referred for the 
evaluation of gastric restrictive surgery in the treatment of 
morbid obesity by her primary care provider ___ 
of ___ in ___.  ___ was 
seen and evaluated in our ___ clinic on 
___ and ___. ___ has class III 
morbid obesity with ___ of 250.2 pounds as of ___ with 
her initial screen ___ of 260.4 pounds on ___, height 64 
inches and BMI of 42.9.  Her previous ___ loss efforts have 
included HMR, the ___ diet, ___ Loss, 
Ideal Protein and self-directed diets losing up to 35 pounds but 
these attempts have failed to produce lasting results.  She has 
not taken prescription ___ loss medications. She stated that 
her lowest adult ___ was 178 pounds in ___ and that her 
highest ___ was her initial screen ___ of 260.4 pounds.  
She weighed 232 pounds in ___, 199 pounds ___ years ago and 218 
pounds in ___.  She stated that she has been struggling with 
___ since early adolescence and cites as factors contributing 
to her excess ___ genetics, large portions, too many 
carbohydrates and saturated fats, convenience eating, emotional 
eating and lack of exercise regimen.  She does routinely walk 
___ times a week for ___ minutes.  She denied history of 
eating disorders - no anorexia, bulimia, diuretic or laxative 
abuse and she denied binge eating.  She does not have clinical 
diagnosis of depression except for situational around her ___ 
and she has been working with a therapist, has not been 
hospitalized for mental health issues and she is not on 
psychotropic medications.
 
Past Medical History:
1)  polycystic ovary syndrome since the age of ___
2)  history of thromboembolism - DVT of left lower extremity 
___
3)  low back pain
4)  borderline type 2 diabetes with hemoglobin A1c of 6.2%
5)  chronic migraine headaches
6)  osteoarthritis of lower extremity joints
7)  bilateral carpal tunnel syndrome
8)  seborrheic dermatitis
9)  vitamin D deficiency
10) hepatic steatosis by ultrasound study
11) low-grade squamous epithelial lesion on Pap
12) ASCUS of cervix with negative high risk HPV
13) positive PPD in ___ treated with isoniazid

Her surgical history is noted for:

1)  left hand carpal tunnel release in ___
2)  tonsillectomy in ___
 
Social History:
___
Family History:
Her family history is noted for father living age ___ with 
diabetes, obesity; mother living age ___ with arthritis and 
myasthenia ___ she has 2 half brothers and 6 half sisters.

 
Physical Exam:
resident exam
Vital Signs: 
Temp: 99.1 PO 
BP: 148/88 
HR: 74 
RR: 14 
O2 sat: 97% O2 RA
 
General: resting comfortably in bed, no acute distress
HEENT: mucus membranes moist, no scleral icterus
Cardio: regular rate and rhythm, S1/S2, no rubs, gallops, 
murmurs
Pulmonary: clear to auscultation bilaterally anteriorly, no
increased work of breathing
Abdomen: dressings removed, steri strips are clean, dry, and
intact, abdomen is soft, appropriately tender
Extremities: warm and well-perfused

 
Pertinent Results:
___ 04:19AM BLOOD Hct-34.7
___ 04:56AM BLOOD Hct-34.6
___ 03:04PM BLOOD Hct-37.0
 
Brief Hospital Course:
The patient presented to pre-op on ___. Patient was 
evaluated by anaesthesia. The patient was taken to the operating 
room for a laparoscopic sleeve gastrectomy for obesity. There 
were no adverse events in the operating room; please see the 
operative note for details. Pt was extubated, taken to the PACU 
until stable, then transferred to the ward for observation.  
 Neuro: The patient was alert and oriented throughout 
hospitalization; pain was initially managed with a PCA. Pain was 
very well controlled. The patient was then transitioned to 
crushed oral pain medication once tolerating a stage 3 diet.  
 CV: The patient remained stable from a cardiovascular 
standpoint; vital signs were routinely monitored.  
 Pulmonary: The patient remained stable from a pulmonary 
standpoint; vital signs were routinely monitored. Good pulmonary 
toilet, early ambulation and incentive spirometry were 
encouraged throughout hospitalization.  
 GI/GU/FEN: The patient was initially kept NPO. Afterwards, the 
patient was started on a stage 1 bariatric diet, which the 
patient tolerated well. Subsequently, the patient was advanced 
to stage 2, and then stage 3 diet which the patient was 
tolerating on day of discharge.  
 ID: The patient's fever curves were closely watched for signs 
of infection, of which there were none.  
 HEME: The patient's blood counts were closely watched for signs 
of bleeding, of which there were none.  
 Prophylaxis: The patient received subcutaneous heparin and ___ 
dyne boots were used during this stay and was encouraged to get 
up and ambulate as early as possible.  On POD1, she was 
transitioned to SC enoxaparin for which she received teaching.  
She will continue this for one month post-operatively given 
history of DVT.
 At the time of discharge, the patient was doing well, afebrile 
and hemodynamically stable. The patient was tolerating a 
bariatric stage 3 diet, ambulating, voiding without assistance, 
and pain was well controlled. The patient received discharge 
teaching and follow-up instructions with understanding 
verbalized and agreement with the discharge plan.  
 
Medications on Admission:
The Preadmission Medication list may be inaccurate and requires 
futher investigation.
1. Ketoconazole 2%  1 Appl TP ASDIR 
2. etonogestrel 68 mg Other ASDIR 
3. Multivitamins 1 TAB PO DAILY 
4. Desonide 0.05% Cream 1 Appl TP AS DIR 
5. Sumatriptan Succinate 50 mg PO DAILY:PRN Headache 
6. SulfaSALAzine_ 1500 mg PO BID 
7. Riboflavin (Vitamin B-2) 200 mg PO QHS 
8. Vitamin D 1000 UNIT PO DAILY 

 
Discharge Medications:
1.  Acetaminophen (Liquid) 650 mg PO Q6H 
RX *acetaminophen 650 mg/20.3 mL 20 ml by mouth every six (6) 
hours Disp #*300 Milliliter Refills:*0 
2.  Docusate Sodium (Liquid) 100 mg PO BID constipation 
RX *docusate sodium 50 mg/5 mL 10 ml by mouth twice a day 
Refills:*0 
3.  Enoxaparin Sodium 40 mg SC Q12H 
RX *enoxaparin 40 mg/0.4 mL 40 mg SC twice a day Disp #*60 
Syringe Refills:*0 
4.  Famotidine 20 mg PO BID 
RX *famotidine 20 mg 1 tablet(s) by mouth twice a day Disp #*60 
Tablet Refills:*0 
5.  OxycoDONE Liquid ___ mg PO Q4H:PRN Pain - Moderate 
RX *oxycodone 5 mg/5 mL ___ mg by mouth every four (4) hours 
Refills:*0 
6.  Desonide 0.05% Cream 1 Appl TP AS DIR  
7.  etonogestrel 68 mg Other ASDIR  
8.  Ketoconazole 2%  1 Appl TP ASDIR  
9.  Multivitamins 1 TAB PO DAILY  
10.  Riboflavin (Vitamin B-2) 200 mg PO QHS  
11.  Sumatriptan Succinate 50 mg PO DAILY:PRN Headache  
12.  Vitamin D 1000 UNIT PO DAILY  
13. HELD- SulfaSALAzine_ 1500 mg PO BID  This medication was 
held. Do not restart SulfaSALAzine_ until you discuss with Dr. 
___.

 
Discharge Disposition:
Home
 
Discharge Diagnosis:
Morbid obesity

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.

 
Discharge Instructions:
Please call your surgeon or return to the Emergency Department 
if you develop a fever greater than ___ F, shaking chills, chest 
pain, difficulty breathing, pain with breathing, cough, a rapid 
heartbeat, dizziness, severe abdominal pain, pain unrelieved by 
your pain medication, a change in the nature or severity of your 
pain, severe nausea, vomiting, abdominal bloating, severe 
diarrhea, inability to eat or drink, foul smelling or colorful 
drainage from your incisions, redness, swelling from your 
incisions, or any other symptoms which are concerning to you.

Diet: Stay on Stage III diet until your follow up appointment; 
please refer to your work book for detailed instructions. Do not 
self- advance your diet and avoid drinking with a straw or 
chewing gum. To avoid dehydration, remember to sip small amounts 
of fluid frequently throughout the day to reach a goal of 
approximately ___ mL per day. Please note the following signs 
of dehydration: dry mouth, rapid heartbeat, feeling dizzy or 
faint, dark colored urine, infrequent urination. 

Medication Instructions:
Please refer to the medication list provided with your discharge 
paperwork for detailed instruction regarding your home and newly 
prescribed medications.  
Some of the new medications you will be taking include:
1.  Pain medication: You will receive a prescription for liquid 
oxycodone, an opioid pain medication.  This medication will make 
you drowsy and impair your ability to drive a motor vehicle or 
operate machinery safely. You MUST refrain from such activities 
while taking these medications. You may also take acetaminophen 
(Tylenol) for pain management; do not exceed 4000 mg per 24 hour 
period.
2. Constipation: This is a common side effect of opioid pain 
medication.  If you experience constipation, please reduce or 
eliminate opioid pain medication.  You may trial 2 ounces of 
light prune juice and/or a stool softener (i.e. crushed docusate 
sodium tablets), twice daily until you resume a normal bowel 
pattern.  Please stop taking this medication if you develop 
loose stools. Please do not begin taking laxatives including 
until you have discussed it with your nurse or surgeon.
3. Antacids: You will be taking famotidine tablets, 20 mg twice 
daily, for one month. This medicine reduces stomach acid 
production. Please crush.
4. You must not use NSAIDS (non-steroidal anti-inflammatory 
drugs). Examples include, but are not limited to Aleve, 
Arthrotec, aspirin, Bufferin, diclofenac, Ecotrin, etodolac, 
ibuprofen, Indocin, indomethacin, Feldene, ketorolac, 
meclofenamate, meloxicam, Midol, Motrin, nambumetone, Naprosyn, 
Naproxen, Nuprin, oxaprozin, Piroxicam, Relafen, Toradol and 
Voltaren. These agents may cause bleeding and ulcers in your 
digestive system. If you are unclear whether a medication is 
considered an NSAID, please ask call your nurse or ask your 
pharmacist.
5.  Vitamins/ minerals: You may resume a chewable multivitamin, 
however, please discuss when to resume additional vitamin and 
mineral supplements with your bariatric dietitian.
6.  Enoxaparin: this medication has been prescribed to reduce 
your risk of forming blood clots.  Please note the following 
instructions regarding this medication: Call your doctor right 
away (24 hours a day,
7 days a week) for any of the following:
-If you cannot get Lovenox from the pharmacy
-Any blood at all in your bowel movements. This would be bloody 
bowel movements, or black, tar-like bowel movements
-Bloody or very dark urine
-Other bleeding that does not stop after 10 minutes
while applying pressure
-A lot of bruises all at once, or a rash or dark spots
under the skin
-Severe stomach pain, nausea, or diarrhea
-Vomiting even a little bit of blood or material that looks like 
coffee grounds
-Signs of an allergic reaction, such as itching, swelling,
trouble breathing, or chest pain
-Headaches, dizziness, or weakness
-If you have a fall, accident, or get hit on the head, even if 
you do not think that you have an injury
-Any other symptom that concerns you
Call ___ for emergencies, such as severe bleeding, fainting, 
difficulty breathing, or chest pain.
Always call ___ for stroke warning signs including sudden:
-Numbness or weakness of the face, arm, or leg, especially on 
one
side of the body
-Confusion or trouble speaking or understanding
-Trouble seeing in one or both eyes
-Trouble walking, dizziness, or loss of balance, or coordination
-Severe headache with no known cause.

Activity:
You should continue walking frequently throughout the day right 
after surgery; you may climb stairs.  
You may resume moderate exercise at your discretion, but avoid 
performing abdominal exercises or lifting items greater than10 
to 15 pounds for six weeks.

Wound Care:
You may remove any remaining gauze from over your incisions.  
You will have thin paper strips (Steri-Strips) over your 
incision; please, remove any remaining Steri-Strip seven to 10 
days after surgery.   
You may shower 48 hours following your surgery; avoid scrubbing 
your incisions and gently pat them dry.  Avoid tub baths or 
swimming until cleared by your surgeon. 
If there is clear drainage from your incisions, cover with 
clean, dry gauze. 
Please call the doctor if you have increased pain, swelling, 
redness, cloudy, bloody or foul smelling drainage from the 
incision sites. 
Avoid direct sun exposure to the incision area for up to 24 
months.
Do not use any ointments on the incision unless you were told 
otherwise.

 
Followup Instructions:
___